SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-075268
Filing Date
2023-06-27
Accepted
2023-06-27 16:22:31
Documents
13
Period of Report
2023-06-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2319705d1_8k.htm   iXBRL 8-K 39976
2 EXHIBIT 10.1 tm2319705d1_ex10-1.htm EX-10.1 112810
  Complete submission text file 0001104659-23-075268.txt   359952

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA eyen-20230627.xsd EX-101.SCH 3227
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyen-20230627_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyen-20230627_pre.xml EX-101.PRE 22359
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2319705d1_8k_htm.xml XML 3706
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 231047588
SIC: 2834 Pharmaceutical Preparations